Home > Media KIt > News Room

Unaudited Financial Results For the Quarter ended 30 September, 2011
Sr. No. Particulars   (Rs. in Lacs)
  Quarter ended  Half Year ended   Year ended
  30.09.2011 30.09.2010 30.09.2011 30.09.2010   31.03.2011
  (Unaudited) (Unaudited)   (Audited)
1 Gross Sales/Income from Operations   6181 5823 12271 10721   21794
  Less: Excise Duty     53 78 123 136   311
(a) Net Sales/Income from Operations   6128 5745 12148 10585   21483
(b) Other Operating Income   3 3 6 3   252
  Total Net Operating Income (1a+1b)   6131 5748 12154 10588   21735
2 Expenditure                
  a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress                  51            122              (87)           (403)              (340)
  b)  Consumption of Raw Materials   3772 3814 8170 7466   14993
  c)  Employee Cost   808 685 1577 1312   2728
  d) Depreciation and Amortisation   1216 1147 2357 2295   4578
  e)  Other Expenditure   998 929 1942 1742   3526
  Total Expenditure     6845 6697 13959 12412   25485
3 Profit / (Loss) from Operations before Other Income, Interest and Exceptional Items (1-2)   (714) 949 (1805) (1824)   (3750)
4  Other Income                     -                 -                  -                 -                    -  
5 Profit / (Loss) before Interest and Exceptional Items (3+4)   (714) 949 (1805) (1824)   (3750)
6  Interest                    210            175              433            315                623
7 Profit / (Loss) after Interest but before Exceptional Items (5-6)   (924) (1124) (2238) (2139)   (4373)
8 Exceptional Items - Income/(Expense)                  -                 -                  -                 -                    -  
9 Profit / (Loss) from Ordinary Activities before Tax (7-8)   (924) (1124) (2238) (2139)   (4373)
10 Tax Expense                 
  - Provision for Earlier Year                  -                 -                  -                 -     (75)
11 Profit / (Loss) from Ordinary Activities after Tax (9-10)   (924) (1124) (2238) (2139)   (4298)
12 Extraordinary Items-Income/(Expense)                  -                 -                  -                 -                    -  
13 Net Profit /(Loss) for the period (11-12)   (924) (1124) (2238) (2139)   (4298)
14 Paid-up Equity Share Capital of Face Value of Rs.2/- each   8996 8996 8996 8996   8996
15 Reserves excluding Revaluation reserves                  -                 -                  -                 -     16765
16 a) Earning Per Share before Extraordinary Items (in Rs.)              
  - Basic & Diluted             (0.21) (0.25)           (0.50) (0.48)   (0.96)
  b) Earning Per Share after Extraordinary Items (in Rs.)              
  - Basic & Diluted             (0.21) (0.25)           (0.50) (0.48)   (0.96)
17 Public Shareholding              
  - Number of Shares   294454615 294454615 294454615 294454615   294454615
  - Percentage of shareholding   65.46% 65.46% 65.46% 65.46%   65.46%
18 Promoters and Promoter Group Shareholding              
  a) Pledged / Encumbered              
  - Number of Shares   610000 610000 610000 610000   610000
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group)   0.39% 0.39% 0.39% 0.39%   0.39%
  - Percentage of shares (as a % of the total share capital of the company)   0.14% 0.14% 0.14% 0.14%   0.14%
  b) Non-encumbered              
  - Number of Shares   154761588 154761588 154761588 154761588   154761588
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group)   99.61% 99.61% 99.61% 99.61%   99.61%
  - Percentage of shares (as a % of the total share capital of the company)   34.40% 34.40% 34.40% 34.40%   34.40%
Notes:                
1. The above results were reviewed by the audit committee and have been approved by the Board of Directors in the meeting held on 9th November, 2011. A limited review of the same had been carried out by the statutory auditors.
2. The Company is exclusively engaged in the Pharmaceutical Business segment.
3. Consolidated Income from Operatitons, Profit(Loss) after tax and EPS for the quarter ended 30th Sep, 2011 stands at Rs.6698 Lacs, Rs.(875) Lacs & Rs. (0.19) respectively.
4. There were no investor complaints pending at the beginning of the quarter. During the quarter, 5 shareholder's complaints were received and 4 complaints have been resolved & 01 complaint is pending to be resolved.
5. Statement of Assets & Liabilities as on 30th September, 2011.
                                                                                                             (Rs.in Lacs)
  Particulars   Half Year ended Half Year ended   Year ended
    30.09.2011 30.09.2010   31.03.2011
  SHAREHOLER'S FUNDS   (Unaudited) (Unaudited)   (Audited)
  -  Share Capital   20961 20961   20961
  -  Reserves and Surplus   24275 24275   24275
  LOAN FUNDS     14311 14066   14205
  TOTAL   59547 59302   59441
                   
  FIXED ASSETS     39566 43719   41658
  INVESTMENTS     12191 12191   12191
  CURRENT ASSETS, LOANS AND ADVANCES          
  - Inventories   3233 3068   3360
  - Sundry Debtors   2406 3200   2773
  - Cash and Bank Balances   336 318   234
  - Loans and Advances   1460 1293   1242
  Less : CURRENT LIABILITIES & PROVISIONS   7435 7879   7609
  - Current Liabilities   8965 9654   9268
  - Provisions   429 319   388
  NET CURRENT ASSETS   (1959) (2094)   (2047)
  MISCELLANEOUS EXPENDITURE                                      -                                   135                128
  (To the extent not written off /adjusted)          
  PROFIT & LOSS ACCOUNT (DEBIT BALANCE)     9749 5351   7511
  TOTAL   59547 59302   59441
            For and on behalf of the Board
                   
                   
Place : New Delhi
Date : 09.11.2011
        (Sushil Suri)
Chairman & Managing Director